U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H16ClN3OS
Molecular Weight 345.846
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-AZANYL-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE

SMILES

CC1=NC2=C(C(N)=C(S2)C(=O)NCC3=CC=C(Cl)C=C3)C(C)=C1

InChI

InChIKey=FPRULFHDSFKYBV-UHFFFAOYSA-N
InChI=1S/C17H16ClN3OS/c1-9-7-10(2)21-17-13(9)14(19)15(23-17)16(22)20-8-11-3-5-12(18)6-4-11/h3-7H,8,19H2,1-2H3,(H,20,22)

HIDE SMILES / InChI

Molecular Formula C17H16ClN3OS
Molecular Weight 345.846
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/18772318

VU 10010 is a selective allosteric potentiator of M4 acetylcholine receptors. VU 10010 had no agonist, antagonist or allosteric potentiator activity at P2Y1R or mGluR5. VU 10010 is selective for M4 relative to other mAChRs - this compound does not displace [3H]NMS binding at any (rM1, rM2, rM3 and rM5) mAChR subtype. VU10010 was not found to be centrally active. It suffers from poor physiochemical properties. Novel analogs of VU10010 are CNS penetrant following systemic administration.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.7 nM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Presynaptic M3 muscarinic cholinoceptors mediate inhibition of excitatory synaptic transmission in area CA1 of rat hippocampus.
2015-12-10
Functional activation of G-proteins coupled with muscarinic acetylcholine receptors in rat brain membranes.
2014
Synaptic muscarinic response types in hippocampal CA1 interneurons depend on different levels of presynaptic activity and different muscarinic receptor subtypes.
2013-10
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.
2008-12
An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.
2008-01
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
The Ki value for ACh at the orthosteric site decreased from 540 ± 72 nM in the absence of VU 10010 to 39 ± 7 nM in the presence of 10 uM VU 10010. These data suggest that this compound binds to an allosteric site on the M4 mAChR and shifts the receptor into a conformation that has higher affinity for ACh.
Substance Class Chemical
Created
by admin
on Wed Apr 02 06:57:10 GMT 2025
Edited
by admin
on Wed Apr 02 06:57:10 GMT 2025
Record UNII
S8GR9YM9MV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3-AZANYL-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE
Systematic Name English
VU-10010
Preferred Name English
THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE, 3-AMINO-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-
Systematic Name English
3-AMINO-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXYLIC ACID 4-CHLORO-BENZYLAMIDE
Systematic Name English
3-AMINO-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYLTHIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
714286
Created by admin on Wed Apr 02 06:57:10 GMT 2025 , Edited by admin on Wed Apr 02 06:57:10 GMT 2025
PRIMARY
EPA CompTox
DTXSID30351931
Created by admin on Wed Apr 02 06:57:10 GMT 2025 , Edited by admin on Wed Apr 02 06:57:10 GMT 2025
PRIMARY
CAS
633283-39-3
Created by admin on Wed Apr 02 06:57:10 GMT 2025 , Edited by admin on Wed Apr 02 06:57:10 GMT 2025
PRIMARY
FDA UNII
S8GR9YM9MV
Created by admin on Wed Apr 02 06:57:10 GMT 2025 , Edited by admin on Wed Apr 02 06:57:10 GMT 2025
PRIMARY